ArticleVaccines2022
In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment.
Jesse W Wotring et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleVaccines2022
Jesse W Wotring et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.